BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15257794)

  • 41. Appropriate time for primaquine treatment to reduce Plasmodium falciparum transmission in hypoendemic areas.
    Wilairatana P; Krudsood S; Tangpukdee N
    Korean J Parasitol; 2010 Jun; 48(2):179-82. PubMed ID: 20585538
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methylene blue induced morphological deformations in Plasmodium falciparum gametocytes: implications for transmission-blocking.
    Wadi I; Pillai CR; Anvikar AR; Sinha A; Nath M; Valecha N
    Malar J; 2018 Jan; 17(1):11. PubMed ID: 29310655
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimethamine in a chloroquine-resistant strain of Plasmodium falciparum.
    Rieckmann KH; McNamara JV; Frischer H; Stockert TA; Carson PE; Powell RD
    Bull World Health Organ; 1968; 38(4):625-32. PubMed ID: 4876731
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia.
    Leang R; Khu NH; Mukaka M; Debackere M; Tripura R; Kheang ST; Chy S; Kak N; Buchy P; Tarantola A; Menard D; Roca-Felterer A; Fairhurst RM; Kheng S; Muth S; Ngak S; Dondorp AM; White NJ; Taylor WR
    BMC Med; 2016 Oct; 14(1):171. PubMed ID: 27784313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A controlled human malaria infection model enabling evaluation of transmission-blocking interventions.
    Collins KA; Wang CY; Adams M; Mitchell H; Rampton M; Elliott S; Reuling IJ; Bousema T; Sauerwein R; Chalon S; Möhrle JJ; McCarthy JS
    J Clin Invest; 2018 Apr; 128(4):1551-1562. PubMed ID: 29389671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanistic Modeling of Primaquine Pharmacokinetics, Gametocytocidal Activity, and Mosquito Infectivity.
    Chotsiri P; Mahamar A; Hoglund RM; Koita F; Sanogo K; Diawara H; Dicko A; Simpson JA; Bousema T; White NJ; Brown JM; Gosling R; Chen I; Tarning J
    Clin Pharmacol Ther; 2022 Mar; 111(3):676-685. PubMed ID: 34905220
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety monitoring experience of single-low dose primaquine co-administered with artemether-lumefantrine among providers and patients in routine healthcare practice: a qualitative study in Eastern Tanzania.
    Mosha D; Kakolwa MA; Mahende MK; Masanja H; Abdulla S; Drakeley C; Gosling R; Wamoyi J
    Malar J; 2021 Oct; 20(1):392. PubMed ID: 34627236
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative efficacies of quinine and chloroquine as companions to primaquine in a curative drug regimen.
    Schmidt LH
    Am J Trop Med Hyg; 1981 Jan; 30(1):20-5. PubMed ID: 7212167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria.
    White NJ; Ashley EA; Recht J; Delves MJ; Ruecker A; Smithuis FM; Eziefula AC; Bousema T; Drakeley C; Chotivanich K; Imwong M; Pukrittayakamee S; Prachumsri J; Chu C; Andolina C; Bancone G; Hien TT; Mayxay M; Taylor WR; von Seidlein L; Price RN; Barnes KI; Djimdé A; ter Kuile F; Gosling R; Chen I; Dhorda MJ; Stepniewska K; Guérin P; Woodrow CJ; Dondorp AM; Day NP; Nosten FH
    Malar J; 2014 Dec; 13():483. PubMed ID: 25486998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glucose-6-phosphate dehydrogenase status and risk of hemolysis in Plasmodium falciparum-infected African children receiving single-dose primaquine.
    Eziefula AC; Pett H; Grignard L; Opus S; Kiggundu M; Kamya MR; Yeung S; Staedke SG; Bousema T; Drakeley C
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4971-3. PubMed ID: 24913169
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does radical cure of asymptomatic Plasmodium falciparum place adults in endemic areas at increased risk of recurrent symptomatic malaria?
    Owusu-Agyei S; Binka F; Koram K; Anto F; Adjuik M; Nkrumah F; Smith T
    Trop Med Int Health; 2002 Jul; 7(7):599-603. PubMed ID: 12100443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Consensual treatment of plasmodium falciparum malaria does not lead to adequate quinine blood concentrations.
    Roger PM; Marty P; Prestifilippo L; Garaffo R; Hyvernat H; Dunais B; Chaillou S; Delaunay P; Bernardin G; Mattéi M; Le Fichoux Y; Dellamonica P
    J Infect; 2002 Oct; 45(3):160-4. PubMed ID: 12387771
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radical cure of infections with Plasmodium cynomolgi: a function of total 8-aminoquinoline dose.
    Schmidt LH; Fradkin R; Vaughan D; Rasco J
    Am J Trop Med Hyg; 1977 Nov; 26(6 Pt 1):1116-28. PubMed ID: 413444
    [No Abstract]   [Full Text] [Related]  

  • 54. Transient lesion in the splenium of the corpus callosum in acute uncomplicated falciparum malaria.
    Laothamatas J; Sammet CL; Golay X; Van Cauteren M; Lekprasert V; Tangpukdee N; Krudsood S; Leowattana W; Wilairatana P; Swaminathan SV; DeLaPaz RL; Brown TR; Looareesuwan S; Brittenham GM
    Am J Trop Med Hyg; 2014 Jun; 90(6):1117-1123. PubMed ID: 24615139
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Study protocol for a randomised controlled double-blinded trial of the dose-dependent efficacy and safety of primaquine for clearance of gametocytes in children with uncomplicated falciparum malaria in Uganda.
    Eziefula AC; Staedke SG; Yeung S; Webb E; Kamya M; White NJ; Bousema T; Drakeley C
    BMJ Open; 2013 Mar; 3(3):. PubMed ID: 23535703
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rationale for short course primaquine in Africa to interrupt malaria transmission.
    Eziefula AC; Gosling R; Hwang J; Hsiang MS; Bousema T; von Seidlein L; Drakeley C;
    Malar J; 2012 Oct; 11():360. PubMed ID: 23130957
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The radical efficacy of pyronaridine-primaquine combination in tertian malaria].
    Huei BL; Shen SL; Wang KS; Gao SF; Cao SZ
    Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1984; 2(4):260-2. PubMed ID: 6394174
    [No Abstract]   [Full Text] [Related]  

  • 58. Dosage of Single Low-Dose Primaquine to Stop Malaria Transmission.
    Cruz M; Sánchez IM; Diaz J; Cuevas F; Silva M; Disla M; Ferreira PE; Veiga MI
    J Infect Dis; 2018 May; 217(11):1849-1850. PubMed ID: 29529291
    [No Abstract]   [Full Text] [Related]  

  • 59. Interactions among primaquine, malaria infection and other antimalarials in Thai subjects.
    Edwards G; McGrath CS; Ward SA; Supanaranond W; Pukrittayakamee S; Davis TM; White NJ
    Br J Clin Pharmacol; 1993 Feb; 35(2):193-8. PubMed ID: 8443039
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Automated erythrocytapheresis as treatment of severe malaria. Study of 6 patients].
    Fernández-Fuertes LF; Tapia-Martín M; Angel-Moreno A; Pisos-Alamo E; Losada-Castillo MC; Díaz-Cremades JM; Pérez-Arellano JL
    Med Clin (Barc); 2008 Sep; 131(8):298-301. PubMed ID: 18803925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.